Stocks making the biggest moves midday: Horizon Therapeutics, Capital One, RH, Home Depot and more

Stocks making the biggest moves midday: Horizon Therapeutics, Capital One, RH, Home Depot and more


In this article

  • HZNP
  • RH
  • HD
  • COF
  • GEHC
Horizon Therapeutics global headquarters in Dublin, Ireland.
Nurphoto | Nurphoto | Getty Images

Check out the companies making the biggest moves midday:

Horizon Therapeutics — Shares of the biotech firm fell 14.17% after the Federal Trade Commission sued to block the company’s acquisition by biopharmaceutical giant Amgen. The deal, worth $27.8 billion, was meant to strengthen Amgen’s drug portfolio as it faces several patent expirations over the next decade for key treatments.

related investing news

This medtech company's shares could jump 20%, Oppenheimer says

CNBC Pro
This medtech company’s shares could jump 20%, Oppenheimer says
Dan Sundheim's D1 buys this large regional bank stock, trims tech holdings in first quarter

CNBC Pro
Dan Sundheim’s D1 buys this large regional bank stock, trims tech holdings in first quarter
Tiger Cub hedge fund Coatue drastically increases Big Tech holdings, doubles down on chip stocks

CNBC Pro
Tiger Cub hedge fund Coatue drastically increases Big Tech holdings, doubles down on chip stocks

Vodafone — U.S.-listed shares of the British telecommunications company dropped 8.73% after Vodafone announced plans to cut 11,000 jobs. CEO Margherita Della Valle said the company’s performance “has not been good enough” and Vodafone “must change.”

Western Alliance Bancorp — Western Alliance shares jumped 2.7% after Bank of America reinstated coverage on the stock with a buy rating. Bank of America said it is confident in the regional bank’s business model. The firm said that “WAL does not share a ton in terms of business model and balance sheet characteristics relative to the three failed banks,” noting its above-average ratio of insured deposits to total deposits. Shares are down 46% year to date.

Capital One — Capital One’s stock gained 2.05% a day after securities filings revealed a new stake in the financial institution from Warren Buffett’s Berkshire Hathaway worth more than $950 million. Regulatory documents also showed Michael Burry’s Scion Asset Management picked up some shares during the first quarter.

RH — Shares of the luxury furniture retailer slid 8.77%. A regulatory filing posted late Monday showed that Warren Buffett’s Berkshire Hathaway dumped its stake last quarter. The Omaha-based conglomerate had owned 2.36 million shares of RH at the end of 2022.

Alphabet — The stock added 2.57%. On Monday, Bill Ackman’s Pershing Square Capital Management revealed in a securities filing that it opened a new position in Alphabet totaling nearly $1.1 billion during the first quarter. Dan Loeb’s Third Point also built a sizeable stake in the tech giant in the first quarter. 

Home Depot, Lowe’s — Shares of home improvement retailers Home Depot and Lowe’s lost 2.15% and 1.16% Tuesday. Home Depot reported the biggest revenue miss in more than 20 years earlier in the day, posting $37.26 billion while analysts forecasted by Refinitiv forecasted $38.28 billion. Lowe’s will report quarterly results on May 23.

Expedia — The travel booking site operator saw its shares rise 0.52% after Gordon Haskett upgraded the stock to buy from hold. The firm said concerns about its tech stack migration are overblown and that it sees a tailwind from traditional lodging offerings. It also highlighted the upcoming launch of its One Key program, which is expected to drive future share gains.

Seagen — Shares of the biotechnology company shed 5.97%. On Monday, Daniel Welch, a director at Seagen, disclosed the sale of 1,864 shares, a stake worth more than $370,000. Seagen and Pfizer also filed paperwork for their proposed merger to the Federal Trade Commission on Friday, just days before the FTC sued to block Amgen’s acquisition of Horizon Therapeutics.

Sea Limited — The consumer internet company dropped 17.74% after slightly missing expectations for first-quarter revenue. The company posted $3.04 billion, under the $3.06 billion consensus estimate of analysts polled by FactSet.

GE HealthCare — The medtech company’s shares gained 3.8% after Oppenheimer initiated coverage with an outperform rating on Monday. The firm said GE HealthCare is well-positioned to benefit from an aging population and rise in cases of chronic diseases. GE HealthCare separated from parent company General Electric earlier in 2023 and began publicly trading on the Nasdaq Jan. 4.

Etsy — The stock sank 5.31% after Morgan Stanley cut its price target to $74 per share from $79, implying 24% downside from Monday’s close. The Wall Street firm said it sees slower growth ahead for Etsy.

—CNBC’s Yun Li, Tanaya Macheel, Alex Harring, Samantha Subin, Hukyung Kim, Brian Evans, Sarah Min and Michael Bloom contributed reporting.



Source

Smaller companies are rising quickly to challenge Big Tech as AI ‘s best trade
Finance

Smaller companies are rising quickly to challenge Big Tech as AI ‘s best trade

ETF Edge Smaller companies are rising quickly to challenge Big Tech as AI ‘s best trade Published Sat, Jan 17 202610:28 AM EST Krysta Escobar WATCH LIVE Source

Read More
Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks
Finance

Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks

Key Points Kevin Hassett told Fox Business that U.S. banks could voluntarily provide credit cards to underserved Americans. President Donald Trump called for banks to cap credit card interest rates at 10%, an idea that has been roundly rejected by industry executives and their lobbyists this week. At least one major credit card issuer and […]

Read More
Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more
Finance

Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more

Check out some of the companies making headlines in midday trading: Novo Nordisk — The maker of the Wegovy obesity treatment jumped more than 4% as sales of its oral weight loss treatment got off to a strong start. In the first week of its launch, about 1.3% of Wegovy prescriptions were for the oral […]

Read More